Clinical significance of sunitinib‐associated macrocytosis in metastatic renal cell carcinoma

Increases in the mean corpuscular volume (MCV) have been observed in patients with metastatic renal cell carcinoma (mRCC) on tyrosine kinase inhibitor (TKI) treatment; however, its association with progression‐free‐survival (PFS) is unknown. We aimed to characterize TKI‐associated macrocytosis in mR...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourlon, Maria T., Gao, Dexiang, Trigero, Sara, Clemons, Julia E., Breaker, Kathryn, Lam, Elaine T., Flaig, Thomas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224865/
https://www.ncbi.nlm.nih.gov/pubmed/27758076
http://dx.doi.org/10.1002/cam4.919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224865/
https://www.ncbi.nlm.nih.gov/pubmed/27758076
http://dx.doi.org/10.1002/cam4.919

Ejemplares similares